Quality Care
Providing evidence-based medical services to improve patient outcomes.
Cancer treatment and research center providing patient care and advancing medical discoveries
About Organization
Dana-Farber Cancer Institute delivers comprehensive cancer care while conducting leading-edge research into prevention and treatment. Located in Boston, MA, the institute operates with $3.5 billion in annual revenue, serving patients and advancing oncology science worldwide.
Quality Care
Providing evidence-based medical services to improve patient outcomes.
Access
Ensuring healthcare availability for diverse populations and communities.
Research
Advancing medical knowledge through clinical studies and innovation.
Form 990 data showing organizational financial health and growth.
Revenue (2023)
$3.5B
+0% vs 2023
Assets (2023)
$5.3B
+0% vs 2023
| Year | Revenue | Expenses | Assets | Employees |
|---|---|---|---|---|
| 2023 | — | — | — | — |
| 2023 | $3,471,594,710 | $3,358,144,757 | $5,348,876,627 | 9,211 |
| 2022 | — | — | — | — |
| 2022 | $3,387,587,769 | $3,002,803,859 | $4,735,245,065 | 8,690 |
| 2021 | — | — | — | — |
| 2021 | $2,669,084,593 | $2,558,704,532 | $4,291,020,227 | 7,998 |
| 2020 | — | — | — | — |
| 2020 | $2,417,795,330 | $2,225,842,004 | $4,549,977,055 | 6,996 |
| 2019 | $2,005,205,411 | $1,969,358,412 | $3,905,849,954 | 6,972 |
| 2018 | $1,985,509,644 | $1,883,293,263 | $3,127,097,000 | 6,457 |
Source: IRS Form 990 filings. All figures in USD.
Conduct evaluations to understand health needs and develop care plans.
Provide evidence-based medical care through qualified healthcare professionals.
Integrate services across specialties for comprehensive patient care.
Monitor health indicators and treatment effectiveness to optimize quality.
Services and programs offered by Dana-Farber Cancer Institute Inc
Grant-funded initiative supporting organizational mission and community needs.
Grant-funded initiative supporting organizational mission and community needs.
Grant-funded initiative supporting organizational mission and community needs.
Grant-funded initiative supporting organizational mission and community needs.
Grant-funded initiative supporting organizational mission and community needs.
Meet the people behind Dana-Farber Cancer Institute Inc.
1962
1962
Dana-Farber Cancer Institute Inc was established to address community needs and advance its mission.
1970
1970
Strengthened governance with expanded board and executive team.
2021
2021
Significant growth in organizational capacity and service delivery.
2023
2023
Demonstrated effectiveness through measurable program outcomes.
Board members, advisors, and key contributors
Information compiled from IRS Form 990 and organizational materials.
Top compensated officers & key employees from IRS Form 990
Total Reported (2023)
$15.4M
Highest Paid
$2.5M
Laurie H Glimcher MD
Compensated Officers
15
| Name | Title | Base | Other | Total | Hrs/Wk |
|---|---|---|---|---|---|
| Laurie H Glimcher MD | Trustee, President & CEO | $2,105,144 | $354,681 | $2,459,825 | 44 |
| William Hahn MD PHD | COO & EVP | $1,299,728 | $50,000 | $1,349,728 | 49 |
| Elizabeth Liebow | Former Key Employee | $1,205,871 | $51,580 | $1,257,451 | — |
| Michael L Reney | CFO & Assistant Treasurer | $1,098,939 | $50,077 | $1,149,016 | 46 |
| Craig A Bunnell MD MPH MBA | Chief Medical Officer | $963,956 | $53,398 | $1,017,354 | 50 |
| Melany Duval | SVP & Chief Philanthropy Officer | $938,328 | $68,330 | $1,006,658 | 50 |
| Robert Soiffer MD | Chair Executive Committee For Clinical Programs | $839,239 | $69,055 | $908,294 | 50 |
| Scott Armstrong MD PHD | Chair Of Pediatric Oncology | $819,691 | $81,122 | $900,813 | 50 |
| Michael Constantine MD | Milford MED DIR-Hematology/Oncology | $800,852 | $89,666 | $890,518 | 50 |
| Bruce Johnson MD | SR. Advisor To President & CEO | $749,341 | $73,538 | $822,879 | 49 |
| Jeffrey Meyerhardt MD MPH | Chief Clinical Research Officer | $720,117 | $89,568 | $809,685 | 50 |
| Jennifer Willcox ESQ | ASST Secretary & General Counsel | $692,134 | $83,219 | $775,353 | 50 |
| Maria Megdal | SVP Chief Administrative Officer | $670,345 | $68,528 | $738,873 | 50 |
| Kevin Haigis PHD | Chief Scientific Officer | $667,828 | $50,797 | $718,625 | 50 |
| Barrett J Rollins MD PHD | SR. Advisor To President & CEO | $546,650 | $57,960 | $604,610 | 50 |
| Name | Title | Base | Other | Total | Hrs/Wk |
|---|---|---|---|---|---|
| Laurie H Glimcher MD | Trustee, President & CEO | $2,000,525 | $338,932 | $2,339,457 | 44 |
| William Hahn MD PHD | COO & EVP | $1,111,718 | $46,513 | $1,158,231 | 48 |
| Michael L Reney | CFO And Assistant Treasurer | $1,020,648 | $46,591 | $1,067,239 | 44 |
| Melany Duval | SVP & Chief Philanthropy Officer | $934,299 | $62,381 | $996,680 | 50 |
| Craig A Bunnell MD | Chief Medical Officer | $877,070 | $49,910 | $926,980 | 50 |
| Scott Armstrong MD | Chair Of Pediatric Oncology | $801,450 | $73,627 | $875,077 | 50 |
| Robert Soiffer MD | Chair Executive Committee For Clinical Programs | $803,536 | $63,739 | $867,275 | 50 |
| Michael Constantine MD | Milford MED DIR-Hematology/Oncology | $773,509 | $65,744 | $839,253 | 50 |
| Bruce Johnson MD | SR. Advisor To President & CEO | $744,812 | $66,936 | $811,748 | 49 |
| Mary-Ellen Taplin MD | Chair Executive Committee For Clinical Research | $714,051 | $57,839 | $771,890 | 50 |
| Kevin Haigis | Chief Scientific Officer | $643,658 | $47,289 | $690,947 | 50 |
| Maria Megdal | SVP Chief Administrative Officer | $619,519 | $62,384 | $681,903 | 50 |
| Jeffrey Meyerhardt MD MPH | Chief Clinical Research Officer | $586,399 | $81,024 | $667,423 | 50 |
| Barrett J Rollins MD PHD | SR. Advisor President & CEO | $529,359 | $63,728 | $593,087 | 50 |
| Elizabeth Liebow | Former Key Employee | $508,850 | $68,051 | $576,901 | — |
| Name | Title | Base | Other | Total | Hrs/Wk |
|---|---|---|---|---|---|
| Laurie H Glimcher MD | Trustee, President, And CEO | $3,672,655 | $321,403 | $3,994,058 | 44 |
| Edward J Benz JR MD | President CEO Emeritus | $2,163,654 | $51,485 | $2,215,139 | 50 |
| Matthew Meyerson MD | Professor | $903,547 | $69,876 | $973,423 | 50 |
| William Hahn MD PHD | COO EVP | $855,136 | $37,402 | $892,538 | 48 |
| Michael L Reney | CFO Assistant Treasurer | $835,469 | $37,481 | $872,950 | 44 |
| Richard S Boskey ESQ | Former Officer | $799,400 | $51,348 | $850,748 | 50 |
| Eric Winer MD | Chief Of Div. Of Women'S Cancers | $797,539 | $47,595 | $845,134 | 50 |
| Michael Constantine MD | Milford Medical DIR. - Hematol Onc. | $758,741 | $58,121 | $816,862 | 50 |
| Craig A Bunnell MD | Chief Medical Officer | $762,033 | $40,568 | $802,601 | 50 |
| Melany Duval | SVP Of Development | $725,483 | $51,770 | $777,253 | 50 |
| Robert Soiffer MD | Chief Of Hemotologic Malignancies | $712,796 | $54,177 | $766,973 | 50 |
| James D Griffin MD | Professor Of Medicine | $681,419 | $59,640 | $741,059 | 50 |
| Bruce Johnson MD | Senior Advisor To President CEO | $671,141 | $56,584 | $727,725 | 49 |
| John Ryan ESQ | ASST. SEC. Gen. Cnsl. (End 1/14/22) | $617,744 | $31,945 | $649,689 | 46 |
| Kevin Haigis | Chief Scientific Officer | $524,839 | $58,480 | $583,319 | 50 |
| Name | Title | Base | Other | Total | Hrs/Wk |
|---|---|---|---|---|---|
| Glimcher Laurie H MD | Trustee, President And CEO | $1,724,225 | $302,393 | $2,026,618 | 44 |
| Benz Edward J JR MD | President And CEO Emeritus | $1,133,382 | $57,427 | $1,190,809 | 50 |
| Reney Michael L | CFO And ASST. Treasurer | $829,041 | $43,894 | $872,935 | 46 |
| Hahn William MD PHD | COO & EVP | $799,032 | $43,460 | $842,492 | 50 |
| Terwilliger James | Former COO & EVP | $815,197 | $24,858 | $840,055 | 48 |
| Bunnell Craig A MD | Chief Medical Officer | $776,215 | $46,443 | $822,658 | 50 |
| Winer Eric MD | Chief Of Div Of Wmns Cancers | $760,184 | $54,768 | $814,952 | 50 |
| Soiffer Robert MD | Chief Of Hemotologic Malig. | $722,519 | $59,949 | $782,468 | 50 |
| Duval Melany | SVP Of Development | $697,803 | $73,719 | $771,522 | 50 |
| Constantine Michael MD | Milford MED DIR-Hematol Onc | $700,983 | $61,137 | $762,120 | 50 |
| Johnson Bruce MD | Chief Cl Res Off(End 9/1/21) | $679,531 | $61,539 | $741,070 | 50 |
| Boskey Richard S ESQ | ASST. SEC. & Gc (End 12/14/20) | $652,019 | $68,313 | $720,332 | 45 |
| Griffin James D MD | Professor Of Medicine | $642,164 | $65,398 | $707,562 | 50 |
| Rollins Barrett J MD PHD | Snr Advisor To President & CEO | $590,875 | $60,481 | $651,356 | 50 |
| Megdal Maria | SVP Of Institute Operations | $527,540 | $58,592 | $586,132 | 50 |
| Name | Title | Base | Other | Total | Hrs/Wk |
|---|---|---|---|---|---|
| Glimcher Laurie H MD | Trustee, President And CEO | $1,714,926 | $298,313 | $2,013,239 | 44 |
| Benz Edward J JR MD | President And CEO Emeritus | $1,361,343 | $57,539 | $1,418,882 | 50 |
| Reney Michael L | CFO And ASST. Treasurer | $835,737 | $45,615 | $881,352 | 46 |
| Winer Eric MD | Chief Of Div Of Wmns Cancers | $812,279 | $54,259 | $866,538 | 50 |
| Bunnell Craig A MD | Chief Medical Officer | $791,644 | $45,953 | $837,597 | 50 |
| Soiffer Robert MD | Chief Of Hemotologic Malig. | $742,645 | $58,825 | $801,470 | 50 |
| Constantine Michael MD | Milford MED DIR-Hematology | $727,056 | $58,012 | $785,068 | 50 |
| Rollins Barrett J MD PHD | Chief Scientific Officer | $722,789 | $60,311 | $783,100 | 50 |
| Armstrong Scott MD | Chair Of Pediatric Oncology | $710,927 | $68,484 | $779,411 | 50 |
| Terwilliger James | COO & EVP | $753,034 | $18,801 | $771,835 | 48 |
| Johnson Bruce MD | Chief Clinical Research Off | $693,952 | $60,341 | $754,293 | 50 |
| Boskey Richard S ESQ | ASST. SEC. & General Counsel | $660,901 | $70,352 | $731,253 | 45 |
| Griffin James D MD | Professor Of Medicine | $657,259 | $64,944 | $722,203 | 50 |
| Hahn William MD PHD | Chief Oper Off (As Of 7/1/20) | $635,549 | $43,452 | $679,001 | 50 |
| Duval Melany | SVP Of Development | $653,960 | $18,320 | $672,280 | 50 |
Source: IRS Form 990 filings. Compensation includes base and other reported compensation.
Economic Injury Disaster Loan Program (2020-2021)
Total Borrowed
$150K
Subsidy Cost
$20K
14% of loan
Loan Count
1
TO PROVIDE LOANS TO RESTORE AS NEARLY AS POSSIBLE THE VICTIMS OF ECONOMIC INJURY TYPE DISASTERS TO PRE-DISASTER CONDITIONS
Source: Small Business Administration • Economic Injury Disaster Loan Program (2020-2021)
Grant funding relationships from IRS Form 990 filings
Source: IRS Form 990 Schedule I filings. Amounts may span multiple tax years.
Government awards and grants from USAspending.gov
| Agency | Award ID | Type | Period | Amount |
|---|---|---|---|---|
| HHS | P50CA100707 | PROJECT GRANT (B) | 2003-2025 | $33,209,515 |
| HHS | P50CA127003 | PROJECT GRANT (B) | 2007-2025 | $30,907,185 |
| HHS | P50CA168504 | PROJECT GRANT (B) | 2013-2025 | $25,026,599 |
| HHS | UM1CA186709 | COOPERATIVE AGREEMENT (B) | 2014-2026 | $23,631,028 |
| HHS | P01AI143565 | PROJECT GRANT (B) | 2020-2025 | $14,830,426 |
| HHS | P01CA229092 | PROJECT GRANT (B) | 2019-2025 | $13,828,168 |
| HHS | R35CA210057 | PROJECT GRANT (B) | 2016-2030 | $9,800,368 |
| HHS | R35CA232128 | PROJECT GRANT (B) | 2019-2026 | $7,195,535 |
| HHS | T32CA136432 | PROJECT GRANT (B) | 2009-2025 | $7,061,692 |
| HHS | R35CA242427 | PROJECT GRANT (B) | 2019-2025 | $7,030,366 |
| HHS | U01AI165442 | COOPERATIVE AGREEMENT (B) | 2021-2026 | $5,922,278 |
| HHS | R01CA259200 | PROJECT GRANT (B) | 2022-2027 | $5,164,514 |
| HHS | U54CA274516 | COOPERATIVE AGREEMENT (B) | 2023-2028 | $5,032,714 |
| HHS | P01AI181597 | PROJECT GRANT (B) | 2024-2029 | $4,613,193 |
| HHS | R01CA201049 | PROJECT GRANT (B) | 2015-2025 | $4,607,248 |
| HHS | R35CA263817 | PROJECT GRANT (B) | 2022-2029 | $4,108,272 |
| HHS | U01CA246648 | COOPERATIVE AGREEMENT (B) | 2020-2025 | $3,731,926 |
| HHS | R01CA251470 | PROJECT GRANT (B) | 2021-2026 | $3,582,879 |
| HHS | U01CA243688 | COOPERATIVE AGREEMENT (B) | 2019-2025 | $3,543,148 |
| HHS | R01CA262577 | PROJECT GRANT (B) | 2022-2027 | $3,342,109 |
+ 80 more awards
Source: USAspending.gov. Amounts represent total federal obligations.